Inadequate dosaging in general practice of tricyclic vs. other antidepressants for depression

Acta Psychiatrica Scandinavica

Volumn 98, Issue 6, 1998, Pages 451-454

  Isometsa E ^a   Seppala I ^b   Henriksson, M ^a   Kekki, P ^b   Lonnqvist J ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antidepressants; Depressive disorders; General practice

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; MIANSERIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE; FINLAND; GENERAL PRACTICE; GENERAL PRACTITIONER; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0031672587     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10118.x     Document Type: Article

References (17)

1. PAYKEL ES, PRIEST RG. Recognition and treatment of depression in general practice: consensus statement. Br Med J 1992;305:1198-1202.
2. SONG F, FREEMANTLE N, SHELDON TA et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J 1993;306:683-687.
3. KASPER S, HÖFLICH G, SCHOLL H-P, MÖLLER H-J. Safety and antidepressant efficacy of selective serotonin reuptake inhibitors. Hum Psychopharmacology 1994;9:1-12.
4. ANDERSON IM, TOMENSON BM. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacology 1994;8:238-249.
5. ANDERSON IM, TOMENSON BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Br Med J 1995; 310:1433-1438.
6. MONTGOMERY SA, HENRY J, MCDONALD G et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacology 1994;9:47-53.
7. HENRY JA, ALEXANDER CA, SENER E. Relative mortality from overdose of antidepressants. Br Med J 1995;310:221-224.
8. JICK SS, DEAN AD, JICK H. Antidepressants and suicide. Br Med J 1995;310:215-218.
9. THOMPSON C, THOMPSON CM. The prescription of antidepressants in general practice. I. A critical review. Hum Psychopharmacology 1989;4:91-102.
10. STURM R, WELLS KB. How can care for depression become more cost-effective? JAMA 1995;273:51-58.
11. ROSHOLM J-U, HALLS J, GRAM LF. Outpatient utilization of antidepressants: a prescription database analysis. J Affect Disord 1993;27:21-28.
12. DONOGHUE JM, TYLEE A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996;168:164-168.
13. MACDONALD TM, MCMAHON AD, REID IC, FFNTON GW, MCDEVITT DG. Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. Br Med J 1996;313:860-861.
14. DONOGHUE JM, TYLEE A, WILDGUST H. Cross-sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-5. Br Med J 1996;313:861-862.
15. STAKES. Depression hoito terveyskeskuksessa. Oppaita 22. Jyväskylä: STAKES, 1994 (National Research and Development Centre for Welfare and Health. Treatment of depression in a health centre. Guidelines 22). Jyväskylä: National Research and Development Centre for Welfare and Health, 1994.
16. National Agency for Medicines and Social Insurance Institution. Finnish statistics on medicines 1995. Helsinki: National Agency for Medicines and Social Insurance Institution, 1996.
17. JOUKAMAA M, SOHLMAN B, LEHTINEN V. The prescription of psychotropic drugs in primary health care. Acta Psychiatr Scand 1995;92:359-364.